Interleukin-1 receptor blockade in perinatal brain injury

Front Pediatr. 2014 Oct 7:2:108. doi: 10.3389/fped.2014.00108. eCollection 2014.

Abstract

Interleukin-1 (IL-1) is a potent inflammatory cytokine that can be produced by a variety of cell types throughout the body. While IL-1 is a central mediator of inflammation and response to infection, the role of IL-1 signaling in adult and pediatric brain injury is becoming increasingly clear. Although the mechanisms of IL-1 expression are largely understood, the downstream effects and contributions to excitotoxicity and oxidative stress are poorly defined. Here, we present a review of mechanisms of IL-1 signaling with a focus on the role of IL-1 in perinatal brain injury. We highlight research models of perinatal brain injury and the use of interleukin-1 receptor antagonist (IL-1RA) as an agent of therapeutic potential in preventing perinatal brain injury due to exposure to inflammation.

Keywords: IL-1; IL-1beta; Kineret; perinatal brain injury; rIL-RA.

Publication types

  • Review